65 companies

PharmaEngine

Market Cap: NT$9.7b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

4162

NT$67.80

7D

1.0%

1Y

-31.0%

Fidson Healthcare

Market Cap: ₦97.1b

Manufactures and distributes pharmaceutical products in Nigeria.

FIDSON

₦42.30

7D

-0.1%

1Y

168.6%

Exelixis

Market Cap: US$9.7b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

EXEL

US$38.05

7D

-3.0%

1Y

35.4%

CytomX Therapeutics

Market Cap: US$559.1m

Operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.

CTMX

US$3.30

7D

0.6%

1Y

205.6%

Memphis Pharmaceuticals & Chemical Industries

Market Cap: ج.م5.0b

A drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally.

MPCI

ج.م219.01

7D

19.0%

1Y

271.2%

Puma Biotechnology

Market Cap: US$263.4m

A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.

PBYI

US$5.04

7D

-6.8%

1Y

80.0%

Catalyst Pharmaceuticals

Market Cap: US$2.6b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

CPRX

US$20.73

7D

1.0%

1Y

-3.2%

Merck

Market Cap: US$218.8b

Operates as a healthcare company worldwide.

MRK

US$87.18

7D

3.9%

1Y

-17.7%

BioStem Technologies

Market Cap: US$81.9m

A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.

BSEM

US$4.86

7D

3.1%

1Y

-65.3%

Consun Pharmaceutical Group

Market Cap: HK$12.7b

Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.

1681

HK$15.18

7D

0.7%

1Y

82.9%

AstraZeneca Pharma India

Market Cap: ₹232.5b

A biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally.

506820

₹9,290.25

7D

1.4%

1Y

30.1%

AGP

Market Cap: PK₨56.3b

Manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products in Pakistan and Afghanistan.

AGP

PK₨201.14

7D

1.6%

1Y

55.7%

Jamjoom Pharmaceuticals Factory

Market Cap: ر.س10.7b

Engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally.

4015

ر.س152.80

7D

-4.4%

1Y

-7.4%

Genmab

Market Cap: DKK 119.3b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

GMAB

DKK 1,938.00

7D

-9.2%

1Y

22.8%

JW Lifescience

Market Cap: ₩208.0b

Provides national infusion solutions in South Korea and internationally.

A234080

₩13,250.00

7D

5.9%

1Y

22.6%

Blue Jet Healthcare

Market Cap: ₹112.9b

Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.

BLUEJET

₹644.70

7D

-1.3%

1Y

36.5%

TTY Biopharm

Market Cap: NT$20.3b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.

4105

NT$81.60

7D

-0.5%

1Y

11.0%

Harmony Biosciences Holdings

Market Cap: US$1.5b

A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.

HRMY

US$29.60

7D

14.1%

1Y

-13.1%

Lupin

Market Cap: ₹886.1b

Operates as a pharmaceutical company in India, the United States, and internationally.

500257

₹1,931.40

7D

-0.4%

1Y

-10.4%

Hoechst Pakistan

Market Cap: PK₨41.5b

Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.

HPL

PK₨4,232.23

7D

5.1%

1Y

80.1%

Alexandria For Pharmaceuticals & Chemical Industries

Market Cap: ج.م4.6b

Manufactures, markets, and distributes generic forms of human and animal health products in Egypt.

AXPH

ج.م912.19

7D

10.1%

1Y

229.6%

ChemoMetec

Market Cap: DKK 12.1b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.

CHEMM

DKK 697.00

7D

6.4%

1Y

67.4%

Shenyang Xingqi PharmaceuticalLtd

Market Cap: CN¥17.8b

Engages in the research and development, production, and sale of ophthalmic medications in the People’s Republic of China.

300573

CN¥74.28

7D

4.1%

1Y

5.7%

WuXi AppTec

Market Cap: CN¥299.7b

An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.

603259

CN¥103.81

7D

7.5%

1Y

95.9%

GlaxoSmithKline Pharmaceuticals

Market Cap: ₹467.5b

Manufactures, distributes, and trades in pharmaceuticals in India and internationally.

500660

₹2,750.25

7D

0.3%

1Y

6.3%

Kahira Pharmaceuticals & Chemical Industries

Market Cap: ج.م4.0b

Engages in the manufacturing and sale of pharmaceuticals, medical preparations, cosmetics, and materials in Egypt.

CPCI

ج.م268.42

7D

14.4%

1Y

189.0%

Medpace Holdings

Market Cap: US$15.4b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

MEDP

US$596.61

7D

14.5%

1Y

81.8%

ADMA Biologics

Market Cap: US$3.6b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

ADMA

US$15.25

7D

4.7%

1Y

-4.4%

ACADIA Pharmaceuticals

Market Cap: US$3.6b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

ACAD

US$21.73

7D

5.4%

1Y

50.1%

L&C BIOLTD

Market Cap: ₩1.3t

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine.

A290650

₩49,750.00

7D

1.8%

1Y

168.5%

HBM Holdings

Market Cap: HK$10.4b

A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.

2142

HK$12.44

7D

-2.7%

1Y

864.3%

Sanjivani Paranteral

Market Cap: ₹2.5b

Operates as a pharmaceutical company in India.

531569

₹199.40

7D

-5.8%

1Y

-24.8%

Jagsonpal Pharmaceuticals

Market Cap: ₹14.5b

Engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally.

JAGSNPHARM

₹215.59

7D

-1.8%

1Y

19.5%

BioSyent

Market Cap: CA$125.6m

Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

RX

CA$11.21

7D

0.09%

1Y

0.4%

Henan Lingrui Pharmaceutical

Market Cap: CN¥13.0b

Produces and sells medicines in China.

600285

CN¥23.08

7D

0.7%

1Y

-4.6%

RPG Life Sciences

Market Cap: ₹38.8b

An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.

RPGLIFE

₹2,354.80

7D

3.4%

1Y

-0.2%

Page 1 of 2